BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38295994)

  • 1. Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer.
    Gong X; Zheng C; Cai Y; Zhang W; Zhu B; Rong R; Kong Y; Zhang Y; Wang J; Li Y; Zhang P
    J Control Release; 2024 Mar; 367():637-648. PubMed ID: 38295994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.
    Wang T; Subramanian C; Yu M; White PT; Kuai R; Sanchez J; Moon JJ; Timmermann BN; Schwendeman A; Cohen MS
    Surgery; 2019 Dec; 166(6):1168-1175. PubMed ID: 31371177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine-loaded synthetic high-density lipoprotein preferentially eradicates hepatic monocyte-derived macrophages in mouse liver with colorectal cancer metastases.
    Xiong FQ; Zhang W; Zheng C; Li Y; Gong X; Zhang Y; Wang H; Zhang PC; Li YP
    Acta Pharmacol Sin; 2023 Nov; 44(11):2331-2341. PubMed ID: 37225846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer.
    Zheng C; Zhang W; Wang J; Zhai Y; Xiong F; Cai Y; Gong X; Zhu B; Zhu HH; Wang H; Li Y; Zhang P
    Acta Pharm Sin B; 2022 Sep; 12(9):3726-3738. PubMed ID: 36176911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.
    Zhang Y; Han X; Wang K; Liu D; Ding X; Hu Z; Wang J
    Int J Nanomedicine; 2023; 18():4329-4346. PubMed ID: 37545872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid conjugate-modified liposomal platform modulates immunosuppressive tumor microenvironment in multiple ways for improved immune checkpoint blockade therapy.
    Li C; Qiu Q; Gao X; Yan X; Fan C; Luo X; Liu X; Wang S; Lai X; Song Y; Deng Y
    J Control Release; 2021 Sep; 337():393-406. PubMed ID: 34171446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.
    Guo Y; Yuan W; Yu B; Kuai R; Hu W; Morin EE; Garcia-Barrio MT; Zhang J; Moon JJ; Schwendeman A; Eugene Chen Y
    EBioMedicine; 2018 Feb; 28():225-233. PubMed ID: 29361501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
    Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
    J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model.
    Dong H; Gao M; Lu L; Gui R; Fu Y
    Int J Nanomedicine; 2023; 18():3577-3593. PubMed ID: 37409026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
    Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
    Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
    Gong M; Zhang Q; Zhao Q; Zheng J; Li Y; Wang S; Yuan Y
    Drug Deliv; 2019 Dec; 26(1):708-716. PubMed ID: 31290708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.
    Fawaz MV; Kim SY; Li D; Ming R; Xia Z; Olsen K; Pogozheva ID; Tesmer JJG; Schwendeman A
    J Pharmacol Exp Ther; 2020 Feb; 372(2):193-204. PubMed ID: 31776208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.
    Kuai R; Subramanian C; White PT; Timmermann BN; Moon JJ; Cohen MS; Schwendeman A
    Int J Nanomedicine; 2017; 12():6581-6594. PubMed ID: 28919755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer.
    Liu Y; Qiu N; Shen L; Liu Q; Zhang J; Cheng YY; Lee KH; Huang L
    J Control Release; 2020 Jul; 323():431-441. PubMed ID: 32360890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy.
    Su L; Hao Y; Li R; Pan W; Ma X; Weng J; Min Y
    Acta Biomater; 2022 Dec; 154():401-411. PubMed ID: 36241013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of established tumors with nanodisc-based combination chemoimmunotherapy.
    Kuai R; Yuan W; Son S; Nam J; Xu Y; Fan Y; Schwendeman A; Moon JJ
    Sci Adv; 2018 Apr; 4(4):eaao1736. PubMed ID: 29675465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
    Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
    J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dual-Targeting Liposome Enhances Triple-Negative Breast Cancer Chemoimmunotherapy through Inducing Immunogenic Cell Death and Inhibiting STAT3 Activation.
    Luo K; Yang L; Yan C; Zhao Y; Li Q; Liu X; Xie L; Sun Q; Li X
    Small; 2023 Oct; 19(40):e2302834. PubMed ID: 37264710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas.
    Subramanian C; Kuai R; Zhu Q; White P; Moon JJ; Schwendeman A; Cohen MS
    Surgery; 2016 Jan; 159(1):284-94. PubMed ID: 26582501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration.
    Mei L; Yu M; Liu Y; Weh E; Pawar M; Li L; Besirli CG; Schwendeman AA
    Nanomedicine; 2022 Aug; 44():102571. PubMed ID: 35623563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.